NeuroSense Therapeutics, Ltd. , a leading clinical-stage biotechnology company focused on developing treatments for severe neurodegenerative diseases, today announced that two members of its ...

Today, Benzinga 's options scanner spotted 50 uncommon options trades for Palantir Technologies. This isn't normal. The ...

Delving into the details, we found 33% of traders were bullish, while 20% showed bearish tendencies. Out of all the trades we spotted, 12 were puts, with a value of $1,146,398, and 3 were calls, ...